Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, DEXCOM, INC. reported revenue of $4.66B, up 15.6% year over year. Operating margin was 19.6% and net margin 17.9%, on a free-cash-flow margin of 23.1% with capital expenditure at 7.8% of revenue. Every figure is computed directly from DXCM's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $4.66B | 19.6% | 17.9% |
| FY2024 | $4.03B | 14.9% | 14.3% |
| FY2023 | $3.62B | 16.5% | 14.9% |
| FY2022 | $2.91B | 13.4% | 11.7% |
| FY2021 | $2.45B | 10.9% | 8.9% |
How does DXCM compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.